News | RIVM

Possible start of COVID-19 vaccination in early January

If all goes well, the first people in the Netherlands will be vaccinated against COVID-19 in early January. The logistics operation aims to start vaccination in the week of 4 January 2021.

Joint Action CHRODIS PLUS: RIVM’s contribution to strengthening Health Promotion

Within the Joint Action for the prevention and treatment of chronic diseases CHRODIS PLUS, RIVM has developed a set of recommendations for intersectoral cooperation to strengthen health promotion a

Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years

National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.

New data on antimicrobial resistance in Europe

New data on antimicrobial resistance (AMR) in European countries is now available in the sixth annual report of the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) netw

International collaboration essential theme State of Zoonoses 2019

Each year, at the request of the Netherlands Food and Consumer Product Safety Authority, RIVM prepares an overview of the most important zoonoses and indicates their prevalence in the Netherlands.

Climate and Energy Outlook 2020: uncertain whether the Netherlands will achieve targets for the reduction of greenhouse gas emissions

The Dutch cabinet’s goal is to reduce greenhouse gas emissions by 49% in 2030, compared to the levels in 1990.

Vaccination rate increased, HPV even significantly

For the first time in five years, the number of children receiving vaccinations from the National Immunisation Programme has increased slightly.

Radioactive substances in the air over Northern Europe

In the first half of June 2020, small amounts of artificial (man-made) radioactive substances have been detected at several measuring stations in Northern Europe.

More reports of adverse effects of implants in 2019

In 2019, the Dutch reporting centre for adverse effects of medical implants (MEBI) received 397 reports of suspected adverse effects. The reports concerned 462 implants.

A decrease in the number of tuberculosis patients in the Netherlands

In 2019, the number of people with tuberculosis (TB) in the Netherlands decreased to 759. This is 5 per cent less than in 2018, when 797 were reported.